Armata Pharmaceuticals (ARMP)

• Market cap: $350M
• 1 day: -0.83%
• 5 days: -19.78%
• 1 month: 17.91%
• 3 months: 69.79%
• 6 months: 224.66%
• Year to date: 46.49%
• 1 year: 371.08%
• 5 years: 74.41%
• 10 years: -98.38%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Employees: 75